• 제목/요약/키워드: TCM treatment

검색결과 191건 처리시간 0.027초

활성화 처리에 따른 소 단위발생란의 발달 (Development of Parthenotes Produced by Various Treatments in Bovine)

  • 이성림;강태영;유재규;여현진;김세나
    • 한국수정란이식학회지
    • /
    • 제16권2호
    • /
    • pp.107-115
    • /
    • 2001
  • 본 연구는 최근 형질전환동물의 생산 및 복제동물 생산에 이용되고 있는 핵이식 기법을 시행할 때 재조합된 핵이식란의 활성화를 위해 널리 적용되고 있는 6-dimethylaminopurine (DMAP)의 활성화 효율과 근래에 제기되고 있는 단위발생란의 비정상적인 염색체 및 핵형에 대해 알아보고 적합한 활성화 유도물질을 찾고자 시행되어졌다. 도축장 유래의 난소에서 채란한 난자를 10% 거세한 수소혈청이 포함된 TCM-199배양에서 22시간동안 체외 성숙을 시킨 후 제 2감수분열 중기의 난자만을 선별해서 5$\mu$M ionomycin에서 5분간 처리하고 1.9 mM 6-dimethylaminopurine (DMAP)와 10$\mu\textrm{g}$/mL cycloheximide (CHX)에서 각 3시간동안 처리하여 활성화를 유도하였다. 활성화가 유도된 난자를 18시간 동안 체외 배양시 전핵 형성, 제 2 세포기까지 분할속도, 배 반포까지의 발달을 및 활성화 및 체외수정 후 108시간에 평균 세포수와 염색체를 분석하여 활성화 물질의 효율뿐만 아니라 문제점을 알아보고자 하였다. 1. 활성화 자극에 따른 난자의 전핵 형성은 ionomycin 처리 후 DMAP을 처리한 난자에서는 1PN 형성율이 9.1%로 ionomycin를 단독 처리하거나 ionomycin 처리 후 CHX를 처리한 난자에서의 1PN 형성율인 77.8와 79.0%보다 유의적 (P<0.05)으로 낮게 나타났으나, 3PN 형성율은 45.5%로 유의적 (P<0.05)으로 높게 나타났다. 따라서 ionomycin 처리 후 DMAP으로 활성화를 유도한 난자는 비정상적인 핵형을 가지지만 CHX로 활성화를 유도하였을 때는 정상적인 전핵 형성이 이루어지는 것으로 보인다. 2. 활성화 자극을 가한 난자의 체외 발달율은 ionomycin을 처리하고 DMAP으로 활성화 자극을 가하였을 때 분할율이 85.5%로 체외 수정한 대조군의 72.5%와 유사하였다. 그러나 ionomycin을 단독 처리하거나 ionomycin 처리 후 CHX로 활성화 자극을 가한 실험군의 분할율인 30.3와 57.9%에 비해 유의적 (P<0.05)으로 높게 나타났다. DMAP 처리군의 분할율은 대조군과 유사하였지만 배반포까지의 발달율은 12.3%로 대조군의 27.8%와는 유의적인 차이는 없으나 발달율이 낮은 경향으로 나타났다. 3. Ionomycin으로 처리 후 DMAP로 활성화 자극을 가한 실험군에서 난자의 발달속도는 활성화 자극 후 18시간 경과하였을 때 28%의 배분열율을 보여 분열속도가 가장 빨랐으며 활성화 자극 후 24~48시간동안 체외 배양을 하였을 때에도 ionomycin 단독 처리하거나 ionomycin 처리 후 CHX로 활성화 자극을 준 실험군에 비해 DMAP으로 활성화 자극을 가한 실험군이 유의적 (P<0.05)으로 빠른 발달속도를 보였다.

  • PDF

한우 수정란의 간이 동결을 위한 유리화 동결법에 관한 연구 (Studies on Cryotop Vitrification Method for Simple Freezing of Hanwoo Embryos)

  • 이해이;김상훈;김용준
    • 한국수정란이식학회지
    • /
    • 제29권1호
    • /
    • pp.13-19
    • /
    • 2014
  • This study was carried out to study the survival rate of thawed Hanwoo embryos frozen by the slow-rate freezing or the cryotop vitrification method. Hanwoo cumulus-oocyte complexes were recovered from ovaries at a slaughter house, matured for 20~22 hours, fertilized with Hanwoo semen for 5~6 hours, and cultured for 7~9 days in $38.5^{\circ}C$, 5% $CO_2$ incubator. For freezing, Day 7~9 blastocysts were collected. Embryos for the slow-rate freezing were equilibrated in 1.8 M ethylene glycol (EG) with Dulbecco's phosphate-buffered saline (D-PBS). Programmable cell freezer was precooled down to $-7^{\circ}C$, and the straw was seeded during 8 minutes-holding time, and was cooled to $-35^{\circ}C$ at the cooling rate of $0.3^{\circ}C/min$, and then was plunged and stored in liquid nitrogen. Embryos for the cryotop vitrification were treated in TCM199 with 0.5 M sucrose, 16% EG, 16% dimethylsulfoxide (DMSO). Embryos were then loaded individually onto cryotop and plunged directly into liquid nitrogen. The survival rates of embryos frozen by these two freezing methods were evaluated at 12 to 24h post-thawing. The survival rates of frozen/thawed Hanwoo embryos by the cryotop vitrification method ($56.86{\pm}26.53%$) were slightly higher than those by the slow-rate freezing method ($55.07{\pm}26.43%$) with no significant difference. Using the cryotop vitrification and the slow-rate freezing of Hanwoo blastocysts on Day 7 following in-vitro fertilization (IVF) treatment, the survival rates of frozen/thawed Hanwoo embryos were $72.65{\pm}18.3%$ and $79.06{\pm}17.8%$, respectively. The survival rates by the cryotop vitrification were higher than those by the slow-rate freezing on both Day 8 and 9 with significantly higher survival rate on Day 9 (p<0.05). Using the cryotop vitrification and the slow-rate freezing of Hanwoo embryos to compare between three different blastocyst stages, the survival rates of the blastocyst stage embryos were $66.22{\pm}18.8%$ and $45.76{\pm}12.8%$, respectively with higher survival rate by the vitrification method (p<0.05). And the survival rate of expanded blastocysts was higher than those of early blastocysts and blastocysts in two freezing methods with significantly higher survival rate by the slow-rate freezing method (p<0.05).

Proliferative and Inhibitory Activity of Siberian ginseng (Eleutherococcus senticosus) Extract on Cancer Cell Lines; A-549, XWLC-05, HCT-116, CNE and Beas-2b

  • Cichello, Simon Angelo;Yao, Qian;Dowell, Ashley;Leury, Brian;He, Xiao-Qiong
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권11호
    • /
    • pp.4781-4786
    • /
    • 2015
  • Siberian ginseng (Eleutherococcus senticosus) is used primarily as an adaptogen herb and also for its immune stimulant properties in Western herbal medicine. Another closely related species used in East Asian medicine systems i.e. Kampo, TCM (Manchuria, Korea, Japan and Ainu of Hokkaido) and also called Siberian ginseng (Acanthopanax senticosus) also displays immune-stimulant and anti-cancer properties. These may affect tumour growth and also provide an anti-fatigue effect for cancer patients, in particular for those suffering from lung cancer. There is some evidence that a carbohydrate in Siberian ginseng may possess not only immune stimulatory but also anti-tumour effects and also display other various anti-cancer properties. Our study aimed to determine the inhibitory and also proliferative effects of a methanol plant extract of Siberan ginseng (E. senticosus) on various cancer and normal cell lines including: A-549 (small cell lung cancer), XWLC-05 (Yunnan lung cancer cell line), CNE (human nasopharyngeal carcinoma cell line), HCT-116 (human colon cancer) and Beas-2b (human lung epithelial). These cell lines were treated with an extract from E. senticosus that was evaporated and reconstituted in DMSO. Treatment of A-549 (small cell lung cancer) cells with E. senticosus methanolic extract showed a concentration-dependent inhibitory trend from $12.5-50{\mu}g/mL$, and then a plateau, whereas at 12.5 and $25{\mu}g/mL$, there is a slight growth suppression in QBC-939 cells, but then a steady suppression from 50, 100 and $200{\mu}g/mL$. Further, in XWLC-05 (Yunnan lung cancer cell line), E. senticosus methanolic extract displayed an inhibitory effect which plateaued with increasing dosage. Next, in CNE (human nasopharyngeal carcinoma cell line) there was a dose dependent proliferative response, whereas in Beas-2 (human lung epithelial cell line), an inhibitory effect. Finally in colon cancer cell line (HCT-116) we observed an initially weak inhibitory effect and then plateau.

햄스터 H-Y항체와 중합효소연쇄반응을 이용한 소 수정란의 성감별 (Sex determination of bovine embryos with hamster H-Y antibody and by polymerase chain reaction)

  • 유일정;김용준;이경광
    • 대한수의학회지
    • /
    • 제39권1호
    • /
    • pp.189-203
    • /
    • 1999
  • To determine sex of bovine embryos using hamster histocompatibility Y(H-Y) antibodies, bovine compact morulae were incubated for 6 hours in TCM199 supplemented with 10% hamster H-Y antiserum and the embryos with developmental arrest were diagnosed as male embryos, while the embryos showing development during the incubation as female embryos. This presumptive embryo sexing was confirmed by polymerase chain reaction(PCR)method. 1. In the result of hamster sperm cytotoxicity test to measure H-Y antibody titer, the rate of dead sperm was considerably lower in H-Y antiserum absorbed with hamster male splenocytes than in H-Y antiserum absorbed with hamster female splenocytes or H-Y antiserum unabsorbed with splenocytes(p<0.01). 2. The rate of oocytes fertilized in vitro and the rate of blastocysts of the fertilized oocytes were 58.5% and 32.4%, respectively. The rate of blastocysts on day 8 was 15.9%, denoting the highest rate during whole culture period posterior to in vitro fertilization (IVF). 3. The bovine 16 cell and compact morulae embryos incubated in the medium supplemented with hamster H-Y antibodies showed 37.1% and 48.9% of developmental arrest which were diagnosed as male, respectively, and rates of redeveloped embryos from the arrested were 24.1% in 16 cell and 44.3% in compact morulae embryos, respectively, denoting higher rate of sex determination and rate of redevelopment in compact morulae than 16 cell embryos. 4. Bovine compact morulae of Korean cattle and Holstein were treated with hamster H-Y antibodies for sex determination and the rates of developmental arrest(diagnosed as male) were 48.4% for Korean cattle and 47.9% for Holstein, respectively. The rates of redeveloped embryos to blastocyst after treatment were 42.6% for Korean cattle and 41.8% for Holstein, respectively, showing no significant differences of sex determination and redevelopment between both breed. 5. The sex determination of bovine embryos(Korean cattle and Holstein) using hamster H-Y antibodies was diagnosed by PCR for confirmation, denoting the rates of 86.1% for Korean cattle and 85.9% for Holstein male embryos, respectively, and the rates of 91.9% for Korean cattle and 90.1% for Holstein female embryos, respectively, with no significant differences of sex determination between both breed. These results indicated that hamster H-Y antibodies can be usable for sex determination of bovine embryos of Korean cattle and Holstein, the viability of bovine embryos was sustained while being cultured in the medium supplemented with hamster H-Y antibodies of appropriate titer and sex determination of bovine embryos by PCR can be feasible for confirmation.

  • PDF

5-Hydroxytryptamine Generates Tonic Inward Currents on Pacemaker Activity of Interstitial Cells of Cajal from Mouse Small Intestine

  • Shahi, Pawan Kumar;Choi, Seok;Zuo, Dong Chuan;Yeum, Cheol-Ho;Yoon, Pyung-Jin;Lee, Jun;Kim, Young-Dae;Park, Chan-Guk;Kim, Man-Yoo;Shin, Hye-Rang;Oh, Hyun-Jung;Jun, Jae-Yeoul
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제15권3호
    • /
    • pp.129-135
    • /
    • 2011
  • In this study we determined whether or not 5-hydroxytryptamine (5-HT) has an effect on the pacemaker activities of interstitial cells of Cajal (ICC) from the mouse small intestine. The actions of 5-HT on pacemaker activities were investigated using a whole-cell patch-clamp technique, intracellular $Ca^{2+}$ ($[Ca^{2+}]_i$) analysis, and RT-PCR in ICC. Exogenously-treated 5-HT showed tonic inward currents on pacemaker currents in ICC under the voltage-clamp mode in a dose-dependent manner. Based on RT-PCR results, we found the existence of 5-$HT_{2B,\;3,\;4,\;and\;7}$ receptors in ICC. However, SDZ 205557 (a 5-$HT_4$ receptor antagonist), SB 269970 (a 5-$HT_7$ receptor antagonist), 3-tropanylindole - 3 - carboxylate methiodide (3-TCM; a 5-$HT_3$ antagonist) blocked the 5-HT-induced action on pacemaker activity, but not SB 204741 (a 5-$HT_{2B}$ receptor antagonist). Based on $[Ca^{2+}]_i$ analysis, we found that 5-HT increased the intensity of $[Ca^{2+}]_i$. The treatment of PD 98059 or JNK II inhibitor blocked the 5-HT-induced action on pacemaker activity of ICC, but not SB 203580. In summary, these results suggest that 5-HT can modulate pacemaker activity through 5-$HT_{3,\;4,\;and\;7}$ receptors via $[Ca^{2+}]_i$ mobilization and regulation of mitogen-activated protein kinases.

Simotang Alleviates the Gastrointestinal Side Effects of Chemotherapy by Altering Gut Microbiota

  • Deng, Lijing;Zhou, Xingyi;Lan, Zhifang;Tang, Kairui;Zhu, Xiaoxu;Mo, Xiaowei;Zhao, Zongyao;Zhao, Zhiqiang;Wu, Mansi
    • Journal of Microbiology and Biotechnology
    • /
    • 제32권4호
    • /
    • pp.405-418
    • /
    • 2022
  • Simotang oral liquid (SMT) is a traditional Chinese medicine (TCM) consisting of four natural plants and is used to alleviate gastrointestinal side effects after chemotherapy and functional dyspepsia (FD). However, the mechanism by which SMT helps cure these gastrointestinal diseases is still unknown. Here, we discovered that SMT could alleviate gastrointestinal side effects after chemotherapy by altering gut microbiota. C57BL/6J mice were treated with cisplatin (DDP) and SMT, and biological samples were collected. Pathological changes in the small intestine were observed, and the intestinal injury score was assessed. The expression levels of the inflammatory factors IL-1β and IL-6 and the adhesive factors Occludin and ZO-1 in mouse blood or small intestine tissue were also detected. Moreover, the gut microbiota was analyzed by high-throughput sequencing of 16S rRNA amplicons. SMT was found to effectively reduce gastrointestinal mucositis after DDP injection, which lowered inflammation and tightened the intestinal epithelial cells. Gut microbiota analysis showed that the abundance of the anti-inflammatory microbiota was downregulated and that the inflammatory microbiota was upregulated in DDP-treated mice. SMT upregulated anti-inflammatory and anticancer microbiota abundance, while the inflammatory microbiota was downregulated. An antibiotic cocktail (ABX) was also used to delete mice gut microbiota to test the importance of gut microbiota, and we found that SMT could not alleviate gastrointestinal mucositis after DDP injection, showing that gut microbiota might be an important mediator of SMT treatment. Our study provides evidence that SMT might moderate gastrointestinal mucositis after chemotherapy by altering gut microbiota.

효율적인 돼지 복제수정란 생산에 관한 연구 1. Ethanol, $Ca^{2+}$ Ionophore, 6-DMAP, Cycloheximide의 농도와 노출시간이 돼지난자의 활성화와 발달에 미치는 영향 (Study of Efficient Production of Cloned Embryos in Porcine 1. Effect of Ethanol, $Ca^{2+}$ Ionophore, 6-DMAP, and Cycloheximide Concentration and Exposure Time on Activation, Cleavage, and In Vitro Development of Porcine Oocytes)

  • 위갑인;김광현;강만종;문승주
    • 한국가축번식학회지
    • /
    • 제27권2호
    • /
    • pp.103-113
    • /
    • 2003
  • 활성화를 통한 수핵란의 대량확보를 위해 44시간동안 체외 성숙된 돼지 난자를 ethanol, $Ca^{2+}$-ionophore, 6-DMAP 및 cycloheximide의 화학물질들을 사용하여 단위발생을 유기한 후 그들의 가장적합한 처리농도 및 노출 시간을 규명하였다. 1. Ethanol은 10%, 10분 처리가 전핵형성율, 난할율 및 배발달율에 있어 각각 약 53.4%, 51.6%, 그리고 39.9%로 가장 적합한 조건으로 판명되었다. 2. $Ca^{2+}$-ionophore 가장 적합한 난활성화 조건은 25$\mu$M에서 2분간 처리한 것이며, 전핵형성율, 난할율 및 배발달율은 각각 약 59.7%, 62.2%, 그리고 43.9%를 보였다. 3. 6-DMAP를 처리하여 돼지 난자의 활성화를 유기하였을 경우 2mM의 농도에서 각각 약 57.3%, 58.4% 및 29.0%의 전핵형성율, 난할율, 그리고 배발달율을 보여 가장 적합한 조건을 보였으며 2시간~4.5시간 사이의 노출에는 영향을 받지 않았다. 4. Cycloheximide는 5$\mu\textrm{g}$/ml의 농도가 전핵형성율 2.1%, 난할율 47.7%, 배발달율 31.8%로 가장 은 효율을 보였고, 노출시간에서는 4시간~6시간 동안 처리하였을 때 60.5~65.8%, 63.6~66.7% 및 39.0~39.5%로 가장 적합한 조건으로 판명되었다. 이상의 결과들은 돼지 체외 성숙 난자의 활성화에 있어 각 화학물질들의 적합한 조건을 바탕으로한 중복처리 및 병용처리 조건 확립 및 효율적인 수핵란의 확보에 기여할 수 있을 것이다.

'아유르베다'($\bar{A}yurveda$)의 의경(醫經)에 관한 연구 (A Study of The Medical Classics in the '$\bar{A}yurveda$')

  • 김기욱;박현국;서지영
    • 대한한의학원전학회지
    • /
    • 제20권4호
    • /
    • pp.91-117
    • /
    • 2007
  • Through a simple study of the medical classics in the '$\bar{A}yurveda$', we have summarized them as follows. 1) Traditional Indian medicine started in the Ganges river area at about 1500 B. C. E. and traces of medical science can be found in the "Rigveda" and "Atharvaveda". 2) The "Charaka" and "$Su\acute{s}hruta$(妙聞集)", ancient texts from India, are not the work of one person, but the result of the work and errors of different doctors and philosophers. Due to the lack of historical records, the time of Charaka or $Su\acute{s}hruta$(妙聞)s' lives are not exactly known. So the completion of the "Charaka" is estimated at 1st${\sim}$2nd century C. E. in northwestern India, and the "$Su\acute{s}hruta$" is estimated to have been completed in 3rd${\sim}$4th century C. E. in central India. Also, the "Charaka" contains details on internal medicine, while the "$Su\acute{s}hruta$" contains more details on surgery by comparison. 3) '$V\bar{a}gbhata$', one of the revered Vriddha Trayi(triad of the ancients, 三醫聖) of the '$\bar{A}yurveda$', lived and worked in about the 7th century and wrote the "$A\d{s}\d{t}\bar{a}nga$ $A\d{s}\d{t}\bar{a}nga$ $h\d{r}daya$ $sa\d{m}hit\bar{a}$ $samhit\bar{a}$(八支集)" and "$A\d{s}\d{t}\bar{a}nga$ Sangraha $samhit\bar{a}$(八心集)", where he tried to compromise and unify the "Charaka" and "$Su\acute{s}hruta$". The "$A\d{s}\d{t}\bar{a}nga$ Sangraha $samhit\bar{a}$" was translated into Tibetan and Arabic at about the 8th${\sim}$9th century, and if we generalize the medicinal plants recorded in each the "Charaka", "$Su\acute{s}hruta$" and the "$A\d{s}\d{t}\bar{a}nga$ Sangraha $samhit\bar{a}$", there are 240, 370, 240 types each. 4) The 'Madhava' focused on one of the subjects of Indian medicine, '$Nid\bar{a}na$' ie meaning "the cause of diseases(病因論)", and in one of the copies found by Bower in 4th century C. E. we can see that it uses prescriptions from the "BuHaLaJi(布哈拉集)", "Charaka", "$Su\acute{s}hruta$". 5) According to the "Charaka", there were 8 branches of ancient medicine in India : treatment of the body(kayacikitsa), special surgery(salakya), removal of alien substances(salyapahartka), treatment of poison or mis-combined medicines(visagaravairodhikaprasamana), the study of ghosts(bhutavidya), pediatrics(kaumarabhrtya), perennial youth and long life(rasayana), and the strengthening of the essence of the body(vajikarana). 6) The '$\bar{A}yurveda$', which originated from ancient experience, was recorded in Sanskrit, which was a theorization of knowledge, and also was written in verses to make memorizing easy, and made medicine the exclusive possession of the Brahmin. The first annotations were 1060 for the "Charaka", 1200 for the "$Su\acute{s}hruta$", 1150 for the "$A\d{s}\d{t}\bar{a}nga$ Sangraha $samhit\bar{a}$", and 1100 for the "$Nid\bar{a}na$", The use of various mineral medicines in the "Charaka" or the use of mercury as internal medicine in the "$A\d{s}\d{t}\bar{a}nga$ Sangraha $samhit\bar{a}$", and the palpation of the pulse for diagnosing in the '$\bar{A}yurveda$' and 'XiZhang(西藏)' medicine are similar to TCM's pulse diagnostics. The coexistence with Arabian 'Unani' medicine, compromise with western medicine and the reactionism trend restored the '$\bar{A}yurveda$' today. 7) The "Charaka" is a book inclined to internal medicine that investigates the origin of human disease which used the dualism of the 'Samkhya', the natural philosophy of the 'Vaisesika' and the logic of the 'Nyaya' in medical theories, and its structure has 16 syllables per line, 2 lines per poem and is recorded in poetry and prose. Also, the "Charaka" can be summarized into the introduction, cause, judgement, body, sensory organs, treatment, pharmaceuticals, and end, and can be seen as a work that strongly reflects the moral code of Brahmin and Aryans. 8) In extracting bloody pus, the "Charaka" introduces a 'sharp tool' bloodletting treatment, while the "$Su\scute{s}hruta$" introduces many surgical methods such as the use of gourd dippers, horns, sucking the blood with leeches. Also the "$Su\acute{s}hruta$" has 19 chapters specializing in ophthalmology, and shows 76 types of eye diseases and their treatments. 9) Since anatomy did not develop in Indian medicine, the inner structure of the human body was not well known. The only exception is 'GuXiangXue(骨相學)' which developed from 'Atharvaveda' times and the "$A\d{s}\d{t}\bar{a}nga$ Sangraha $samhit\bar{a}$". In the "$A\d{s}\d{t}\bar{a}nga$ Sangraha $samhit\bar{a}$"'s 'ShenTiLun(身體論)' there is a thorough listing of the development of a child from pregnancy to birth. The '$\bar{A}yurveda$' is not just an ancient traditional medical system but is being called alternative medicine in the west because of its ability to supplement western medicine and, as its effects are being proved scientifically it is gaining attention worldwide. We would like to say that what we have researched is just a small fragment and a limited view, and would like to correct and supplement any insufficient parts through more research of new records.

  • PDF

아유르베다'($\bar{A}yurveda$) 의경(醫經)에 관한 연구 (A Study of The Medical Classics in the '$\bar{A}yurveda$')

  • 김기욱;박현국;서지영
    • 동국한의학연구소논문집
    • /
    • 제10권
    • /
    • pp.119-145
    • /
    • 2008
  • Through a simple study of the medical classics in the '$\bar{A}yurveda$', we have summarized them as follows. 1) Traditional Indian medicine started in the Ganges river area at about 1500 B. C. E. and traces of medical science can be found in the "Rigveda" and "Atharvaveda". 2) The "Charaka(閣羅迦集)" and "$Su\acute{s}hruta$(妙聞集)", ancient texts from India, are not the work of one person, but the result of the work and errors of different doctors and philosophers. Due to the lack of historical records, the time of Charaka(閣羅迦) or $Su\acute{s}hruta$(妙聞)s' lives are not exactly known. So the completion of the "Charaka" is estimated at 1st$\sim$2nd century C. E. in northwestern India, and the "$Su\acute{s}hruta$" is estimated to have been completed in 3rd$\sim$4th century C. E. in central India. Also, the "Charaka" contains details on internal medicine, while the "$Su\acute{s}hruta$" contains more details on surgery by comparison. 3) '$V\bar{a}gbhata$', one of the revered Vriddha Trayi(triad of the ancients, 三醫聖) of the '$\bar{A}yurveda$', lived and worked in about the 7th century and wrote the "$Ast\bar{a}nga$ $Ast\bar{a}nga$ hrdaya $samhit\bar{a}$ $samhit\bar{a}$(八支集) and "$Ast\bar{a}nga$ Sangraha $samhit\bar{a}$(八心集)", where he tried to compromise and unify the "Charaka" and "$Su\acute{s}hruta$". The "$Ast\bar{a}nga$ Sangraha $samhit\bar{a}$" was translated into Tibetan and Arabic at about the 8th$\sim$9th century, and if we generalize the medicinal plants recorded in each the "Charaka", "$Su\acute{s}hruta$" and the "$Ast\bar{a}nga$ Sangraha $samhit\bar{a}$", there are 240, 370, 240 types each. 4) The 'Madhava' focused on one of the subjects of Indian medicine, '$Nid\bar{a}na$' ie meaning "the cause of diseases(病因論)", and in one of the copies found by Bower in 4th century C. E. we can see that it uses prescriptions from the "BuHaLaJi(布唅拉集)", "Charaka", "$Su\acute{s}hruta$". 5) According to the "Charaka", there were 8 branches of ancient medicine in India : treatment of the body(kayacikitsa), special surgery(salakya), removal of alien substances(salyapahartka), treatment of poison or mis-combined medicines(visagaravairodhikaprasamana), the study of ghosts(bhutavidya), pediatrics(kaumarabhrtya), perennial youth and long life(rasayana), and the strengthening of the essence of the body(vajikarana). 6) The '$\bar{A}yurveda$', which originated from ancient experience, was recorded in Sanskrit, which was a theorization of knowledge, and also was written in verses to make memorizing easy, and made medicine the exclusive possession of the Brahmin. The first annotations were 1060 for the "Charaka", 1200 for the "$Su\acute{s}hruta$", 1150 for the "$Ast\bar{a}nga$ Sangraha $samhit\bar{a}$", and 1100 for the "$Nid\bar{a}na$". The use of various mineral medicines in the "Charaka" or the use of mercury as internal medicine in the "$Ast\bar{a}nga$ Sangraha $samhit\bar{a}$", and the palpation of the pulse for diagnosing in the '$\bar{A}yurveda$' and 'XiZhang(西藏)' medicine are similar to TCM's pulse diagnostics. The coexistence with Arabian 'Unani' medicine, compromise with western medicine and the reactionism trend restored the '$\bar{A}yurveda$' today. 7) The "Charaka" is a book inclined to internal medicine that investigates the origin of human disease which used the dualism of the 'Samkhya', the natural philosophy of the 'Vaisesika' and the logic of the 'Nyaya' in medical theories, and its structure has 16 syllables per line, 2 lines per poem and is recorded in poetry and prose. Also, the "Charaka" can be summarized into the introduction, cause, judgement, body, sensory organs, treatment, pharmaceuticals, and end, and can be seen as a work that strongly reflects the moral code of Brahmin and Aryans. 8) In extracting bloody pus, the "Charaka" introduces a 'sharp tool' bloodletting treatment, while the "$Su\acute{s}hruta$" introduces many surgical methods such as the use of gourd dippers, horns, sucking the blood with leeches. Also the "$Su\acute{s}hruta$" has 19 chapters specializing in ophthalmology, and shows 76 types of eye diseases and their treatments. 9) Since anatomy did not develop in Indian medicine, the inner structure of the human body was not well known. The only exception is 'GuXiangXue(骨相學)' which developed from 'Atharvaveda' times and the "$Ast\bar{a}nga$ Sangraha $samhit\bar{a}$". In the "$Ast\bar{a}nga$ Sangraha $samhit\bar{a}$"'s 'ShenTiLun(身體論)' there is a thorough listing of the development of a child from pregnancy to birth. The '$\bar{A}yurveda$' is not just an ancient traditional medical system but is being called alternative medicine in the west because of its ability to supplement western medicine and, as its effects are being proved scientifically it is gaining attention worldwide. We would like to say that what we have researched is just a small fragment and a limited view, and would like to correct and supplement any insufficient parts through more research of new records.

  • PDF

재래산양의 체세포 핵이식에 의한 복제수정란의 체외발달에 관한 연구 (Studies on the In Vitro Development of Cloned Embryos by Somatic Cell Nuclear Transfer in Korean Native Goats)

  • 박희성;김태숙;정수영;이윤희;정장용
    • 한국수정란이식학회지
    • /
    • 제20권2호
    • /
    • pp.105-112
    • /
    • 2005
  • 본 연구는 재래산양에서 복제 수정란의 생산효율을 향상시키기 위한 기초 자료를 제시하고자 체세포 핵이식을 실시하여 공핵세포의 종류, 핵이식란의 활성화 처리 방법 및 수핵난자의 조건이 체외발달율에 미치는 영향을 조사, 검토하여 핵이식란 생산을 위한 최적의 조건을 규명하고자 실시하였다. 공핵세포의 종류에 따른 핵이식란의 체외발달율은 융합이 이루어진 핵이식란의 활성화 처리 후 분할율은 귀 유래 섬유아세포를 공핵세포로 사용하였을 때가 $40.5\%$로서 태아 유래 섬유아세포를 공핵세포로 사용하였을 때의 $55.5\%$와 유의적인 차이가 없었다. 또한 상실배 또는 배반포기로의 발달율도 각각 $6.7\%$$16.0\%$로서 유의적인 차이가 없었다. 핵이식란의 활성화 방법에 따른 체외발달율은 ionomycin+6-DMAP 처리를 하였을 때 분할율은 $79.0\%$로서 전기자극을 주었을 때의 $9.5\%$보다는 유의적(P<0.05)으로 높았다. 상실배 또는 배반 포기로의 발달율도 ionomycin+6-DMAP 처리를 하였을 때는 $15.6\%$가 발달하였으나, 전기 자극을 주었을 때는 4-세포기 이후로의 발달이 전혀 이루어지지 않았다. 체세포 핵이식란은 단위발생란에 비하여 분할율$(66.1\%\;vs\;59.18\%)$ 및 상실배 또는 배반포배로의 발달율$(19.0\%\;vs\;0.0\%)$이 유의적 (P<0.05)으로 낮았다. 단위발생란의 분할율은 체내 성숙난자에서 $86.8\%$로서 난포란의 $69.0\%$보다는 유의적(P<0.05)으로 높았다 단위발생란의 상실배 또는 배반포기로의 발달율에 있어서도 체내 성숙난자$(50.0\%)$가 난포란$(23.6\%)$보다 유의적 (p.<0.05)으로 발달율이 높았다. 이상의 결과로 볼 때 재래산양의 체세포를 이용한 복제수정란의 생산효율을 향상시키기 위해서는 다수의 난자 확보를 위한 과배란처리 방법의 개선, 난포란의 이용효율 개선 및 활성화 처리방법 등이 확립되어야 하며, 후기배로의 발달율 향상을 위해서는 최적의 체외 배양조건 확립이 시급한 것으로 생각된다.